Canary Capital Spins up Delaware Trust for Staked Injective ETF
- On June 9, 2025, Canary Capital filed to establish a statutory trust in Delaware for an ETF focused on Injective's native token, INJ, aimed at providing exposure to staked assets.
- This trust registration follows Canary's previous filings for staking ETFs including TRX in April and CRO in May, marking early steps subject to SEC approval.
- The ETF would give investors exposure to INJ price movements and staking rewards, offering a regulated way to earn passive income without technical staking complexities.
- Canary's filings align with recent market trends where similar products launched in Europe, and the firm pursues multiple crypto ETFs reflecting a broader strategy.
- This registration represents a significant move toward staking-based crypto ETFs in the U.S. that could influence regulatory acceptance and expand investment options for crypto-curious investors.
14 Articles
14 Articles
Canary Capital Files Staked Injective ETF Trust in Delaware
Key Highlights: Canary Capital registers a Delaware trust for a Staked Injective ETF. It’s a key move toward U.S. market entry and SEC approval. The ETF will combine INJ price tracking with staking yields, offering retail and institutional investors passive income potential. INJ’s price jumped 4.5% following the ETF filing. Bullish momentum is aiming for the next resistance at $15.40. Canary Capital has formally registered a statutory trust in …
INJ’s Price Surges Over 5% After Canary Capital Files for a Staked Injective ETF
Canary Capital has filed a trust in Delaware for an INJ staking ETF. The move seeks to offer staking exposure to the Injective token. The news sparks a 3.7% gain in INJ over the last 24 hours. Asset management firm Canary Capital has filed for a trust in Delaware to create a product offering staking exposure to the Injective (INJ) token, a move that pushes the boundaries of crypto-based financial products in the United States. The development, …
Key Points of the News Canary Capital creates a Delaware trust for INJ's "ETF in stacking", which marks the first step towards a possible launch of an ETF focused on Injective native token. The proposed ETF seeks to offer investors a double exposure: capture the fluctuations in INJ's price and, at the same time, offer rewards for stacking, a novel advantage in the ETF sector. This initiative aligns with the growing trend of altcoins' ETFs in the…


Staked Injective ETF in sight as Canary Capital registers Delaware trust
Canary Capital has registered a Delaware trust for a staked Injective ETF, marking an early step toward potentially launching a tradable INJ product in the U.S. Canary Capital has established a trust for an exchange-traded fund offering exposure to staked Injective ( INJ ). The trust, named “Canary...
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium